1 Scientific Responsibility in an Age of Terrorism: Codes of Conduct for the Bioscience/medical Community Brian Rappert & Malcolm Dando.

Slides:



Advertisements
Similar presentations
THE NIH RECOMBINANT DNA 2002 GUIDELINES East Carolina University September 5, 2007.
Advertisements

Future International Environmental Security Issues and Potential Military Requirements over the period of 2010 to for the U.S. Army Environmental.
Biotechnology Chapter 11.
Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.
Brian J. Gorman, M.Sc., J.D. Towson University, Maryland Presentation for The National Academies’ Committee on Scientific Communication and National Security.
“The Life Sciences, Biosecurity, and Dual Use Research” Designed by: Brian Rappert Malcolm Dando University of Exeter Bradford University Marie Chevrier.
The Seminar is being held 11am to 12.30pm in Room 104 upstairs.
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
Addressing Synthetic Biology and Biosecurity
Dual-Use Examples Lecture No. 15 Further Inf. For further information and video link please click on the right buttons in the following slides.
Dual-Use: The Fink Report
The Select Agent Laboratory: at the intersection of research, preparedness and safety Nancy Connell,PhD Professor and Vice-chair for Research Department.
Draft Lecture No 14 By Malcolm Dando. I. Outline The concept of dual-use Slides The Fink Committee Report –A. Objective and structure of the report.
DNA Technology. Biotechnology The use or alteration of cells or biological molecules for specific applications Transgenics Transgenic “changed genes”
CHAPTER 31 Genetic Engineering and Biotechnology.
The International Regulation of Biotechnology Lecture No. 19.
Dual-Use Examples Lecture No. 15
General Microbiology (Micr300) Lecture 11 Biotechnology (Text Chapters: ; )
Overview of the Lectures in the Education Module Resource Lecture No. 1.
From T. MADHAVAN, M.Sc., M.L.I.S., M.Ed., M.Phil., P.G.D.C.A., Lecturer in Zoology.. EXIT.
Immunity & Disease. What is DNA? What is DNA Day?
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Synthetic biology Genome engineering Chris Yellman, U. Texas CSSB.
Biotechnology Unit 6. I. What is biotechnology? Biotechnology is a the use of living systems and organisms to develop or make useful products. Today we.
THE BASIS FOR TRANSGENIC ORGANISMS. TRANSFORMATION The incorporation of a piece of naked DNA (not attached to cells) from one organism into the DNA of.
Syllabus CBE3014 – Genetic Engineering (유전공학)
Bacterial Genetics Dr. Zaheer Ahmed Chaudhary Associate Professor Microbiology Department of Pathology.
Types of vaccines 1 - First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. [1] Live, attenuated vaccines,
Gene Technology Section 1: Genetic Engineering
Introduction to the MUSC Institutional Biosafety Committee (IBC) Registration Process Daniel Eisenman, PhD MUSC Biosafety Officer
AP Biology Ch. 20 Biotechnology.
歐亞書局 PRINCIPLES OF BIOCHEMISTRY Chapter 9 DNA-Based Information Technologies.
Image 1 – Tomato seedling iStockphoto/Thinkstock, Image 2 – Fermenter iStockphoto/Thinkstock 2011, Image 3 – Wheat Hermerara/Getty Images, Image 4 –DNAConfig.
What Is Biotechnology? An Introduction BioScience Survey An Introduction BioScience Survey.
RS–IAP-ICSU, September 2006 NSABB National Science Advisory Board on Biosecurity Dual Use Research: Scope, Criteria and Communication.
Chapter 20: Viruses and Prokaryotes
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Biotechnology and Recombinant DNA
Dual Use Research of Concern Boston University and Boston Medical Center.
A symposium presented by the IUPS Ethics Committee 37 th Congress IUPS Birmingham UK July 2013.
Excellence in science The Royal Society is the independent scientific academy of the UK dedicated to promoting excellence in science. Royal Society’s work.
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
Biotechnology and Genetic Engineering. Human Cloning-The Science In The News.
Synthetic Biology and Illegal Weapon Development Promises, Promises Brett Edwards.
Copyright © 2010 Pearson Education, Inc. Lectures prepared by Christine L. Case Chapter 9 Biotechnology and Recombinant DNA.
World Health Organization Life science research: opportunities and risks for public health Ottorino Cosivi Department of Epidemic and Pandemic Alert and.
Section 1 Genetic Engineering Basic Steps of Genetic Engineering Genetic Engineering Genetic engineers manipulate DNA for practical purposes. Restriction.
BIOTECHNOLOGY.
North Carolina DNA Day ON DEMAND Immunity & Disease.
OUTLINE OF SECURITY PROPOSAL Malcolm Dando. 1. The Original Design of the EMR Web of Prevention – Intelligence, Export Controls, Arms Control The Biological.
Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and.
Human Embryos and Gene-editing Research and regulation in China Prof. Zhihong Xu, Peking University & Chinese Academy of Sciences.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
UNDERSTANDING BIOTERRORISM: Tara O’Toole, MD, MPH The United States Conference of Mayors Mayors Emergency, Safety & Security Summit October 24, 2001.
Genetic Engineering/ Recombinant DNA Technology
Viruses Versus Living Organisms
Ch 2 Mouse Mischief. Scientists understand how cholera outbreaks happen because of vaccinations epidemiology genetics.
A new player in the innate immunity game? Scientists have demonstrated for the first time that a certain class of RNA (known as long non-protein-coding.
Immunity Viruses and Bacteria
"When does new science become a threat?".. problem - experimentation - discovery The scientific process.
1 The Argument for Oversight: Developments in the US John Steinbruner University of Maryland Controlling Dangerous Pathogens Project: Regional Workshop.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
What is Biotechnology? How Long have humans used Biotechnology?
Chapter 18 - Viruses. Structure A virus is a non-living particle A virus is a non-living particle Composed of DNA or RNA and a protein coat Composed of.
Biotechnology and DNA Technology
Biosafety and Recombinant DNA Technology
Lesson 2 – Recombinant DNA (Inquiry into Life pg )
More biomedical research challenges
Agenda 4/8 Biotech Intro Uses for Bacteria and Viruses
UN BWC Meeting of States Parties
Presentation transcript:

1 Scientific Responsibility in an Age of Terrorism: Codes of Conduct for the Bioscience/medical Community Brian Rappert & Malcolm Dando

2 What We are Doing ESRC Project: Coding Research: Biological Weapons, Security & the Silencing of Science How, if at all, might regulatory controls challenge the existing norms and conduct of research? How can policy makers develop new approaches for minimising bioweapon threats through engagement with bioscience communities? Can codes of conduct be a viable and effective policy option? Starting Points: Importance of keeping the conversation going; testing out views Ethics & Research: Information sheets, consent, & contact

3 Cause for Concern?: Synthetic Polio Virus In 2002 Wimmer et al. (State University of New York) synthesised chemically polio virus Over a few years made to order DNA segments & public sequence info used to construct full-length cDNA version, then a viable virus Danger: Suggested technique for synthetically creating other viruses (e.g. Ebola New Scientist) Controversy: Novel? Necessary? Should it have been done?

4 Cause for Concern? ‘I think it's inflammatory, without scientific justification...To purposely make a synthetic human pathogen is irresponsible.’ Venter, NYT, July 2002 November 2003 Craig Venter et al. synthesise the bacteriophage phi-X174 from segments “We have the enabling technology to take us to these next exciting frontiers” Dr Craig Venter Is artificial synthesis still a good idea? Improved process with less contamination, took 14 days Funded by US Department of Energy to find new ways of environmental clean- up

5 Mousepox: What Should be Done? 2001 Australian researchers employ mousepox to immunize mice against egg protein, insertion of the IL-4 gene to > antibody response Recombinant virus killed mice genetically resistant to mousepox and those immunized against it ‘Unforeseen’ potential for >> lethality of smallpox To publish or not to publish? Should such experimental results have been made public and how?

6 Responding to Bioweapons Threats: Keeping Ahead Through Research Leaked US Initiatives (1) Genetically enhance the potency of the bacterium that causes anthrax to test defenses (2) Assembled and tested of an old Soviet cluster germ bomb (w/stimulant) (3) Built bioweapon plant from commercially available materials (w/stimulant) Should we always seek to ‘run faster’?

7 US Fink Committee: What is Being Done New research controls: Post 9-11 and anthrax attacks in the US Recommendations include expansion of NIH rDNA review procedures for ‘experiments of concern’ including: - How to make vaccine ineffective - Alter host range of pathogen - Enhance virulence of pathogen - Confer resistance to useful antibiotics & antivirals Proposals submitted to Local Institutional Biosafety Committee, perhaps to national expanded RAC for ‘assessment’ Establishment of National Science Advisory Board for Biosecurity to review, survey and educate bioscientists Is review procedure reasonable, dangerous, etc?

8 Spanish Flu: What Should be Done? 1918 ‘Spanish’ flu killed ~30 million 1997 US Armed Forces Institute of Pathology isolate and sequence nine fragments of viral RNA; full sequencing now near completion Recombinant viruses of influenza formed using 1918 flu genes; molecular analysis possible Are there any limits on what should be done or how it is communicated?

9 Data Access and Genomics Research Data access – info, biomaterials, etc. – as negotiated e.g., Hilgartner, S In Private Science HGP Single Chromosome Workshops in 1990s ‘Gene Hunters’: to share or not to share? Strategic calculations: delayed release, not submit to Genome Data Base, decline to release clones Forced requirement for presented materials to be made public Other examples from Yeast Sequencing, Sequence- Tagged Sites In practice does science work according to free and open communication?

10 Beyond Bugs Fink Committee: ‘The Committee has initially limited its concerns to cover those possibilities that represent a plausible danger…Over time, however, the Committee believes that it will be necessary to expand the experiments of concern to cover a significantly wider range of potential threats.’ Bioregulators and Weaponry US/UK historical interest in ‘incapacitants’ (e.g., 3-quinuclidinyl benzilate) Pennsylvania State University, The Advantages and Limitations of Calmatives for Use as a Non-Lethal Technique (2000) Drug classes: Benzodiazepines, α 2 adrenergic receptor agonists, Dopamine D3 receptor agonists Conflict between serving nation and not developing biochemical weapons?

11 UK Controls: A Code of Conduct? Concern wider than biosafety/security: Risk of novel threats from research results or techniques ‘Codes of Conduct’: Royal Society, Foreign Office, ICRC, BMA, and House of Commons Committees. S&T Committee ‘urge scientific learned societies to consider introducing an overt ethical code of conduct as a prerequisite of membership’ into the scientific profession Biological Weapons Convention international meeting in 2005 about codes UK Foreign Office as chair What individual and collective responsibilities should be included?

12 Forthcoming Codes “If the scientific community does not take stronger action to regulate itself then it risks having ill-judged restrictions placed on it by politicians.” -- UK House of Commons Science & Technology Committee (2003)

13 “Every major technology - metallurgy, explosives, internal combustion, aviation, electronics, nuclear energy - has been intensively exploited, not only for peaceful purposes but also for hostile ones. Must this also happen with biotechnology, certain to be a dominant technology of the twenty-first century?” Matthew Meselson Professor of Molecular Biology, Harvard University What steps might be taken by you as individuals and by bioscience bodies to avoid this happening?

14 Thank You For further information: Provide contact details Codes:

15 Further References Alberts, B. & May, R ‘Scientists Support for Biological Weapons Controls’ Science (November 8):1135. British Medical Association Biotechnology, Weapons and Humanity London: Hardwood Academic. Cello, C., Paul, A. & Wimmer, E ‘Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template’ Science 297: Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, Development, Security, and Cooperation Biotechnology Research in an Age of Terrorism Washington, DC: National Research Council. Dando M The New Biological Weapons Boulder: Lynne Rienner. Foreign and Commonwealth Office Strengthening the Biological and Toxin Weapons Convention London: HMSO.

16 Further References Hilgartner, S ‘Data Access Policy in Genome Research’ In Private Science A. Thackray (ed.) Philadelphia: University of Pennsylvania. Jackson, R. Ramsay, A., Christensen, C., Beaton, S. Hall, D., & Ramshaw, I ‘Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox’ Journal of Virology 75(3): National Science Advisory Board for Biosecurity Poste, G Advances in Biotechnology: Promise or Peril. Available at Rappert, B ‘Coding Ethical Behaviour: The Challenges of Biological Weapons’ Science & Engineering Ethics 9(4) Available at